Cardiopulmonary exercise testing in COVID-19 patients at 3 months follow-up
- PMID: 34311011
- PMCID: PMC8302817
- DOI: 10.1016/j.ijcard.2021.07.033
Cardiopulmonary exercise testing in COVID-19 patients at 3 months follow-up
Abstract
Background: Long-term effects of Coronavirus Disease of 2019 (COVID-19) are of utmost relevance. We aimed to determine: 1) the functional capacity of COVID-19 survivors by cardiopulmonary exercise testing (CPET); 2) the characteristics associated with cardiopulmonary exercise testing (CPET) performance; 3) the safety and tolerability of CPET.
Methods: We prospectively enrolled consecutive patients with laboratory-confirmed COVID-19 from Azienda Sanitaria Locale 3, Genoa. Three months after hospital discharge a complete clinical evaluation, trans-thoracic echocardiography, CPET, pulmonary function tests, and dominant leg extension (DLE) maximal strength measurement were performed.
Results: From the 225 patients discharged alive from March to November 2020, we excluded 12 incomplete/missing cases and 13 unable to perform CPET, leading to a final cohort of 200. Median percent-predicted peak oxygen uptake (%pVO2) was 88% (78.3-103.1). Ninety-nine (49.5%) patients had %pVO2 below, whereas 101 (50.5%) above the 85% predicted value. Among the 99 patients with reduced %pVO2, 61 (61%) had a normal anaerobic threshold: of these, 9(14.8%) had respiratory, 21(34.4%) cardiac, and 31(50.8%) non-cardiopulmonary reasons for exercise limitation. Inerestingly, 80% of patients experienced at least one disabling symtpom, not related to %pVO2 or functional capacity. Multivariate linear regression showed percent-predicted forced expiratory volume in one-second(β = 5.29,p = 0.023), percent-predicted diffusing capacity of lungs for carbon monoxide(β = 6.31,p = 0.001), and DLE maximal strength(β = 14.09,p = 0.008) to be independently associated with pVO2. No adverse event was reported during or after CPET, and no involved health professional developed COVID-19.
Conclusions: At three months after discharge, about 1/3rd of COVID-19 survivors show functional limitations, mainly explained by muscular impairment, calling for future research to identify patients at higher risk of long-term effects that may benefit from careful surveillance and targeted rehabilitation.
Keywords: COVID-19; Cardiopulmonary exercise testing; Coronavirus; Coronavirus infection; Lung diseases; Severe acute respiratory syndrome.
Copyright © 2021 Elsevier B.V. All rights reserved.
Conflict of interest statement
The Authors declare that there is no conflict of interest.
Figures
Comment in
-
Exercise ventilatory inefficiency may be a relevant CPET-feature in COVID-19 survivors.Int J Cardiol. 2021 Nov 15;343:200. doi: 10.1016/j.ijcard.2021.09.026. Epub 2021 Sep 17. Int J Cardiol. 2021. PMID: 34537303 Free PMC article. No abstract available.
References
-
- Worldometer https://www.worldometers.info/coronavirus/
-
- Cardiology . 2020. TESf. ESC Guidance for the Diagnosis and Management of CV Disease during the COVID-19 Pandemic.
-
- Kurz D.J., Eberli F.R. Cardiovascular aspects of COVID-19. Swiss Med. Wkly. 2020;150:w20417. - PubMed
-
- Madjid M., Safavi-Naeini P., Solomon S.D., Vardeny O. Potential effects of coronaviruses on the cardiovascular system: a review. JAMA Cardiol. 2020;5(7):831–840. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical